Helius Medical Technologi...

NASDAQ: HSDT · Real-Time Price · USD
6.44
0.01 (0.16%)
At close: Aug 19, 2025, 3:59 PM
6.25
-2.95%
Pre-market: Aug 20, 2025, 08:32 AM EDT

Helius Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
295K 434K 520K 502K 594K 668K 644K 792K 845K 708K 787K 763K 676K 628K 522K 455K 477K 539K
Cost of Revenue
558K 580K 582K 518K 550K 654K 692K 792K 721K 634K 644K 630K 616K 597K 541K 642K 615K 652K
Gross Profit
-263K -146K -62K -16K 44K 14K -48K n/a 124K 74K 143K 133K 60K 31K -19K -187K -138K -113K
Operating Income
-14.55M -14.5M -13.9M -13M -11.93M -11.88M -12.27M -12.69M -13.79M -14.01M -14.76M -16.17M -16.45M -19.19M -18.12M -17.04M -16.33M -13.78M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-21.29M -13.06M -11.74M -8.86M -8.84M -8.87M -8.85M -12.69M -10.06M -12.22M -14.07M -13.29M -16.95M -19.12M -18.13M -16.56M -15.35M -12.73M
Net Income
-21.29M -13.06M -11.74M -8.86M -8.84M -8.87M -8.85M -12.69M -10.06M -12.22M -14.07M -13.29M -16.95M -19.12M -18.13M -16.56M -15.35M -12.73M
Selling & General & Admin
10.47M 10.48M 10.12M 9.57M 8.92M 9.03M 9.27M 9.61M 10.8M 10.7M 10.64M 11.03M 10.5M 12.78M 12.12M 11.85M 11.34M 8.88M
Research & Development
3.77M 3.82M 3.66M 3.38M 3.03M 2.84M 2.94M 3.09M 3.12M 3.38M 4.26M 5.28M 6.01M 6.44M 5.99M 5.01M 4.85M 4.78M
Other Expenses
50K 57K 64K 29K 22K 15K 8K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
14.29M 14.35M 13.84M 12.99M 11.97M 11.89M 12.22M 12.69M 13.92M 14.08M 14.9M 16.31M 16.51M 19.22M 18.11M 16.86M 16.19M 13.66M
Interest Expense
628K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
651K 651K 651K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
14.85M 14.93M 14.42M 13.5M 6.25M -681K -8.15M -13.48M -14.64M -14.71M -15.55M -16.94M -17.13M -19.82M -18.65M -17.5M -16.81M -14.31M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
2.47K 2.71M 2.71M 3.74M 2.52M 1.63M 1.43M 1.34M 1.13M 1.13M 440.81K 341.73K 157.15K 151.51K 125.26K 93.07K 92.69K 81.63K
Shares Outstanding (Diluted)
2.47K 2.71M 2.71M 3.74M 2.52M 1.63M 1.43M 1.34M 1.13M 1.13M 440.81K 341.73K 157.15K 151.51K 125.26K 93.07K 92.69K 81.63K
EPS (Basic)
-3.99K -4.5 -4.62 -3.9 -5.65 -6.47 -7.14 -17.49 -17.76 -40.54 -67.01 -88.68 -136.03 -176.31 -188.81 -200.35 -217.39 -225.26
EPS (Diluted)
-3.99K -4.5 -4.62 -3.9 -5.65 -6.47 -7.14 -17.49 -17.76 -40.54 -67.01 -88.68 -136.03 -176.31 -188.81 -200.35 -217.39 -225.26
EBITDA
-20.35M -14.41M -13.8M -12.93M -12.49M -10.82M -9.85M -12.46M -9.8M -11.94M -13.77M -12.94M -16.61M -18.79M -17.79M -16.21M -14.98M -12.31M
EBIT
-20.39M -14.46M -13.86M -13M -12.6M -10.97M -10.05M -12.69M -10.06M -12.22M -14.07M -13.29M -16.95M -19.12M -18.13M -16.56M -15.35M -12.73M
Depreciation & Amortization
45K 52K 60K 69K 108K 153K 200K 232K 260K 284K 306K 344K 337K 329K 344K 356K 378K 419K